Category : Search result: dementia specialist


SBI SO 2025: 996 Vacancies, Apply by Dec 23

State Bank of India has started online registration for SBI Specialist Officer Recruitment 2025 for 996 posts. Apply at sbi.bank.in/careers before December 23. Check eligibility and steps here.

Childhood Colds Trigger Ear Infections: ENT Alert

Frequent colds in children are causing recurrent ear infections, warns ENT specialist Dr. Ravi Kanojia. Learn prevention tips and when to seek medical help for your child's ear health.

Punjab Cabinet Nods 300 Specialist Doctors

Punjab cabinet approves empanelment of 300 specialist doctors, new border area incentives, GPS mining vehicle tracking & revised tender limits to boost public services.

Punjab Approves 300 Specialist Doctors for Better Healthcare

Punjab Cabinet approves empanelment of 300 specialist doctors across 12 domains to improve healthcare services. This initiative will enhance specialist availability and quality of medical care across government facilities in the state.

Punjab to Hire 300 Private Specialist Doctors

Punjab government announces empanelment of 300 private specialist doctors to address critical shortage in government hospitals. Learn how this initiative will improve healthcare access.

Bank Recruitment 2025: 3000+ Jobs Before Dec 1

Major banking recruitment drives offer 3000+ vacancies across BOI, Bank of Baroda, IPPB & Central Bank. Application deadlines approach November 30-December 1. Apply now for stable banking careers!

6 Daily Routines for Better Dementia Care

Discover how structured daily routines can reduce agitation and improve emotional stability for dementia patients. Expert tips from Indian neurologists and care specialists.

Alzheimer's Drug Donanemab Approved in India

Eli Lilly's Alzheimer's drug donanemab gets Indian regulatory approval. The treatment slows cognitive decline by 35.1% and could be available next year. Learn about its benefits and pricing.

Alzheimer's Drug Donanemab Approved for India

Eli Lilly's Alzheimer's drug donanemab gets Indian regulator nod. The treatment slows cognitive decline by 35.1% and is expected to launch in India next year. Details on pricing and safety.

Page 1 of 2